TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP)

Historical Holders from Q1 2014 to Q3 2017

Type / Class
Equity / COM NEW
Symbol
TNXP on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2017 Q3 0 $0 -$1,602,000 0
2017 Q2 370,000 $1,602,000 +$194,514 432.97% 1
2017 Q1 318,510 $1,487,000 -$2,999,458 466.81% 3
2016 Q4 2,775,463 $1,302,258 -$775,371 46.95% 23
2016 Q3 4,011,964 $2,794,000 -$7,613,799 69.72% 33
2016 Q2 8,727,075 $17,365,740 +$780,558 199% 46
2016 Q1 8,007,807 $19,293,000 -$10,630,755 240.86% 47
2015 Q4 9,161,514 $70,265,000 +$215,822 766.96% 48
2015 Q3 9,237,332 $48,865,000 +$8,804,991 529% 49
2015 Q2 7,442,329 $66,697,000 +$8,406,975 896.9% 45
2015 Q1 6,482,071 $40,966,000 +$22,891,246 631.98% 30
2014 Q4 2,863,047 $16,716,000 +$635,508 583.7% 28
2014 Q3 2,724,811 $18,638,020 +$140,775 685% 25
2014 Q2 2,584,226 $37,073,960 -$5,592,430 1,434.9% 17
2014 Q1 3,076,248 $32,019,000 +$24,720,607 1,040.89% 21